Vimarsana
Biggest News Aggregation in the World

Men Treated News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Men Treated. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Men Treated Today - Breaking & Trending Today

Olympus Announces iTindtm Treatment Milestone with Availability Through Major GPOs - Vimarsana News

Olympus Announces iTindtm Treatment Milestone with Availability Through Major GPOs

Olympus, a leading global medtech company providing innovative solutions for medical and surgical procedures, announced today a milestone for its iTindtm device with its availability and greater patient access through the largest healthcare group...

Study Proves iTind Treatment for Enlarged Prostate Lasts More than Four Years - Vimarsana News

Study Proves iTind Treatment for Enlarged Prostate Lasts More than Four Years

/PRNewswire/ -- Olympus Corporation, a global medical technology company, announced publication of study data demonstrating that the minimally invasive iTind™...

CentralAsia: Число пострадавших при взрыве автобуса в Воронеже выросло до 22 - Vimarsana News

CentralAsia: Число пострадавших при взрыве автобуса в Воронеже выросло до 22

Количество пострадавших в результате взрыва пассажирского автобуса в Воронеже, который произошел в четверг, выросло до 22. Об этом сообщил губернатор региона Александр Гусев.

ВЗГЛЯД / Число пострадавших при взрыве автобуса в Воронеже выросло до 24 человек :: Новости дня - Vimarsana News

ВЗГЛЯД / Число пострадавших при взрыве автобуса в Воронеже выросло до 24 человек :: Новости дня

Губернатор Воронежской области Александр Гусев сообщил, что количество пострадавших в результате взрыва пассажирского автобуса выросло до 24 человек, двое из них погибли, в больницах остаются 16 человек

Source: vz.ru
ASCO GU 2021: Best of Journals: Prostate Cancer - Vimarsana News

ASCO GU 2021: Best of Journals: Prostate Cancer

Published 13 February 2021 (UroToday.com) The 2021 American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium included a prostate cancer session 'Best of Journals' with Dr. Keyan Salari providing the surgical perspective. Dr. Salari selected two studies assessing active surveillance in Black men with low-risk prostate cancer, and one study assessing the timing of radiation therapy after radical prostatectomy. The first paper was by Deka et al. “Association Between African American Race and Clinical Outcomes in Men Treated for Low-Risk Prostate Cancer with Active Su...